Gemphire Announces Top-Line Data from Familial Partial Lipodystrophy (FPLD) Phase 2a Proof-of-Concept NAFLD/NASH Clinical Trial

NEXT STORY
XBiotech Wins “Commercial Real Estate Award for Industrial Development” for its Headquarters in Austin, Texas
PREV STORY
Amunix Pharmaceuticals Announces the Appointment of Dr. Bryan Irving as Chief Scientific Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ascendis Pharma A/S Introduces Vision 3×3: A Strategic Roadmap Through 2025 to Achieve Sustainable Growth Using Multiple Approaches

author_avatar
NASDAQ Market News

In-vitro Diagnostics (IVD) Market to Reach $118.5 Billion by 2027, Growing at a CAGR of 7% From 2020 with COVID-19 Impact- Meticulous Research® Analysis

author_avatar
NASDAQ Market News

Global Large Molecule Bioanalytical Testing Services Market Report 2021: Increased Applications in Clinical Trials of Biomarkers & Large Molecules

author_avatar
NASDAQ Market News